About
Peter Weijmarshausen is a founder and former CEO of Shapeways who has built software and product teams across multiple companies. He holds a BSc in Applied Physics and is now developing a platform for artificial virus-based cancer therapeutics.
Peter Weijmarshausen @weijmarshausen
I am thrilled to announce the successful close of Humane Genomics Series Seed financing led by @usv ! Supporting lead candidate from lab to the clinic and building the platform. Many thanks to new and existing investors, partners, and the incredible team. https://t.co/VPZ5gfp5IS
Feb 13, 2025 Β· β₯ 2 Β· β 1
Peter Weijmarshausen @weijmarshausen
Thank you @SteveKerr for saying this. I hope if enough people speak up they may hear us. https://t.co/CocC6bAxiv #EnoughIsEnough
May 25, 2022 Β· β₯ 3 Β· β 1
Peter Weijmarshausen @weijmarshausen
Stoked that @FierceBiotech published https://t.co/5tf3RqJ7OO a great post by @amirahalidrus about what we are doing at Humane Genomics. (YC S21)!!
Aug 27, 2021 Β· β₯ 1
Founder at Humane GenomicsYC S21
Intro paths
Peter went through Y Combinator (Summer 2021) β any YC alum in your network can reach them through the YC community.
In turn, Peter can intro founders to Humane Genomics's investors below.
Humane Genomics's investors Β· 7
Co-founders at Humane Genomics
